Comparison of Three Combination Chemotherapy Regimens in Treating Women With Stage I or Stage II Breast Cancer

Sponsor
Royal Marsden NHS Foundation Trust
Study ID
NCT00004237
Phase
PHASE2
Status
Completed

Conditions

Eligibility Criteria

Sex
FEMALE
Age
18 Years - 70 Years
Healthy Volunteers
Not accepted

Interventions

  • cyclophosphamide — DRUG
  • doxorubicin hydrochloride — DRUG
  • epirubicin hydrochloride — DRUG
  • mitoxantrone hydrochloride — DRUG
  • vinorelbine tartrate — DRUG
  • conventional surgery — PROCEDURE
  • radiation therapy — RADIATION

Study Details

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: This randomized phase II trial is studying three regimens of combination chemotherapy to compare how well they work in treating women with stage I or stage II breast cancer.

Key Dates

First listed
Jan 27, 2003
Start date
Oct 31, 1998
Status verified
May 2005
Completion
Sep 30, 2005

Study Design

Allocation
RANDOMIZED
Primary purpose
TREATMENT

Related Studies